America needs more monkeys.
To be more precise, the pharmaceutical industry in the United States needs them. Scientists are warning that a shortage of non-human primates (NHPs)—which have served as test subjects for Parkinson’s therapies, coronavirus vaccines, and a host of other medical treatments, preventatives, and cures—is imperiling U.S. drug development and medical research.
Alec Dent is a former culture editor and staff writer for The Dispatch.
